A 58-year-old man undergoes elective open cholecystectomy for symptomatic cholelithiasis. On post-operative day 5, he develops fever (38.5°C), purulent wound discharge, and erythema at the incision site. Regarding the management and prevention of this surgical site infection, all of the following are appropriate EXCEPT:

Question

Accepted Answer

C. Routine use of negative-pressure wound therapy (NPWT) immediately upon diagnosis of superficial SSI to accelerate healing and reduce antibiotic duration. ## Management of Surgical Site Infection: Post-Operative Day 5

**Key Point:** This patient has a **superficial incisional SSI** (erythema, purulent discharge, fever on POD 5). Management requires wound exploration, culture, antibiotics, and source control — but NOT all adjunctive measures are indicated for superficial SSI.

### Clinical Presentation & Classification

- **Timing:** POD 5 (within 30 days of surgery) → SSI
- **Depth:** Erythema and purulent discharge at incision site → **Superficial incisional SSI** (not deep or organ-space)
- **Signs:** Fever, purulence, erythema → Confirmed infection

### Appropriate Management Steps

#### 1. Wound Exploration & Culture (Option 0) ✓
**Correct.** Essential first steps:
- Open incision at bedside or in OR (depending on severity)
- Explore for loculated pus, necrotic tissue, or fascial involvement
- Send wound fluid/tissue for:
  - Gram stain
  - Aerobic & anaerobic culture
  - Antibiotic susceptibility testing
- Debride any necrotic or devitalized tissue

**Clinical Pearl:** Superficial SSI often does NOT require formal OR exploration if purulence can be drained at bedside; however, if there is concern for deeper involvement (fluctuance, crepitus, systemic toxicity), formal exploration is mandatory.

#### 2. Empiric Broad-Spectrum Antibiotics (Option 1) ✓
**Correct.** Pending culture results:
- **Typical SSI pathogens:** *Staphylococcus aureus* (including MRSA), *Streptococcus pyogenes*, gram-negative enterobacteria (*E. coli*, *Klebsiella*), anaerobes (*Bacteroides*, *Clostridium*)
- **Recommended empiric coverage:**
  - Piperacillin-tazobactam (covers gram-positive, gram-negative, anaerobes)
  - OR Carbapenem (meropenem, imipenem) if MRSA risk or beta-lactam allergy
  - OR Fluoroquinolone + clindamycin (if allergy to beta-lactams)
- **De-escalate** once culture & susceptibility results available

#### 3. Negative-Pressure Wound Therapy (NPWT) (Option 2) ✗
**INCORRECT.** NPWT is NOT routinely indicated for superficial SSI and is **not standard of care** for this scenario.

**High-Yield:** NPWT indications are:
- **Deep or complex wounds** (deep incisional SSI, organ-space SSI)
- **Large open wounds** with significant tissue loss
- **Chronic wounds** (pressure ulcers, diabetic foot ulcers)
- **Wounds with high exudate** or poor healing trajectory

**Why NOT for superficial SSI?**
- Superficial SSI typically heals well with simple drainage, debridement, and antibiotics
- NPWT adds cost (~$100–500/day), complexity, and potential complications (bleeding, skin maceration)
- No evidence that NPWT reduces antibiotic duration or improves outcomes in superficial SSI
- Standard care: open drainage, daily dressing changes, antibiotics

#### 4. Modifiable Risk Factor Modification (Option 3) ✓
**Correct.** Essential for prevention of recurrence and future infections:
- **Glycemic control:** Tight perioperative glucose (target 140–180 mg/dL) reduces SSI risk
- **Nutritional support:** Adequate protein, vitamin C, zinc promote wound healing
- **Smoking cessation:** Improves tissue oxygenation and immune function
- **Weight management:** Obesity is an independent SSI risk factor

**Clinical Pearl:** These interventions are part of **Enhanced Recovery After Surgery (ERAS)** protocols and reduce SSI recurrence by 20–30%.

### Summary: When to Use NPWT

```mermaid
flowchart TD
  A[Surgical Site Infection Diagnosed]:::outcome --> B{Depth of Infection?}:::decision
  B -->|Superficial Incisional| C[Simple drainage + antibiotics + dressing changes]:::action
  B -->|Deep Incisional or Organ-Space| D[Formal exploration + debridement]:::action
  D --> E{Large open wound or high exudate?}:::decision
  E -->|Yes| F[Consider NPWT]:::action
  E -->|No| G[Standard dressing + antibiotics]:::action
  C --> H[Modify risk factors]:::action
  G --> H
  F --> H
```

**Mnemonic:** **DCAB** for SSI management:
- **D**rainage (open incision, remove pus)
- **C**ulture (identify organism)
- **A**ntibiotics (empiric, then targeted)
- **B**enefit from risk factor modification (not NPWT for superficial cases)

Answer

A. Immediate wound exploration, debridement of necrotic tissue, and culture of wound fluid for organism identification and antibiotic susceptibility

Answer

B. Empiric broad-spectrum antibiotics (e.g., piperacillin-tazobactam or carbapenems) pending culture results, covering gram-positive, gram-negative, and anaerobic organisms

Answer

D. Identification and modification of modifiable risk factors (glycemic control, nutritional status, smoking cessation) to prevent recurrent infection

Explanation

Practice similar questions